SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Teva Pharmaceuticals
TEVA 35.55+4.3%Feb 2 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Doug who wrote (127)11/17/1997 5:52:00 AM
From: Gary105  Read Replies (1) of 340
 
Doug, the best I can do is the following:

1. Consensus estimates: quote.yahoo.com

2. Re copaxone - in rereading some of the articles, I see that the $40M estimate for copaxone is for 1997. Plus the Lehman article estimates much higher level copaxone '98 sales. Therefore I believe much of the increase for next yr is copaxone projections. But the company has been growing sales and earnings without copaxone - how much of the increase is due to copaxone requires more study - offhand I would say about half. I welcome comments from others on this.

Gary
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext